Transcatheter arterial embolization for massive hepatocellular carcinoma in 18 dogs (2020–2025)
American Journal of Veterinary Research · 01.11.2026 · 87 (11)
DOI: 10.2460/ajvr.26.04.0189 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Veterinary Research, erschienen am 01.11.2026. Verfasst von Ko Kadowaki und 3 weiteren Autor:innen. Beteiligte Einrichtung: Japan Animal Cardiovascular Care Team, Osaka, Japan. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Dog Diseases, Liver Neoplasms, Embolization, Therapeutic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
To report tumor response, complications, outcomes, and extrahepatic collateral arterial supply presence in dogs with massive hepatocellular carcinoma (HCC) treated with transcatheter arterial embolization (TAE). Animals 18 dogs diagnosed with massive HCC. Clinical Presentation All dogs underwent contrast-enhanced CT and pretreatment histopathologic confirmation by laparoscopic biopsy (n = 1) or ultrasound-guided needle core biopsy (17). Tumor response was assessed using percentage of change in tumor volume on CT before TAE and 1 to 3 months after TAE.
Results
Post-TAE tumor response was classified as partial response in 9 of 18 (50.0%), stable disease in 6 of 18 (33.3%), and progressive disease in 1 of 18 (5.6%). Two dogs (11.1%) died within 2 weeks after TAE. The median percentage of change in tumor volume, excluding those 2 dogs, was −32.6%. Extrahepatic collateral arterial supplies to tumors were identified in 13 of 18 (72.2%), including the gastroepiploic (22.2%), right phrenic (22.2%), left phrenic (27.8%), pancreatic (16.7%), and mesenteric (5.6%) arteries. Collateral supply from 2 and 3 vessels was observed in 3 of 18 (16.7%) and 1 of 18 (5.6%), respectively; second TAE was performed in 2 of 18 (11.1%) and hepatic lobectomy after TAE in 4 of 18 (22.2%) cases. Postoperative complications included mild diarrhea (77.8%), anorexia (61.1%), mild anemia (16.7%), and acute gallbladder infarction (11.1%) etc. Both cases of gallbladder infarction were asymptomatic with good clinical outcomes. Median survival time was 447 days, including all 18 dogs. Transcatheter arterial embolization achieved disease control in most dogs and often involved extrahepatic collaterals. Clinical Relevance TAE may be a useful option in selected dogs with massive HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Japan Animal Cardiovascular Care Team, Osaka, Japan.
- Laboratory of Veterinary Internal Medicine, Department of Clinical Sciences, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
- Kinki Animal Medical Center, Osaka, Japan.
ORCID-Profile: Ko Kadowaki, Ryuhei Yamamoto
Zitieren
APA
Kadowaki, K., Nishimura, S., Toyoda, A., & Yamamoto, R. (2026). Transcatheter arterial embolization for massive hepatocellular carcinoma in 18 dogs (2020–2025). American Journal of Veterinary Research, 87(11). https://doi.org/10.2460/ajvr.26.04.0189
Vancouver
Kadowaki K, Nishimura S, Toyoda A, Yamamoto R. Transcatheter arterial embolization for massive hepatocellular carcinoma in 18 dogs (2020–2025). American Journal of Veterinary Research. 2026;87(11). doi:10.2460/ajvr.26.04.0189
BibTeX
@article{Kadowaki2026,
author = {Kadowaki, Ko and Nishimura, Shin and Toyoda, Akihiro and Yamamoto, Ryuhei},
title = {Transcatheter arterial embolization for massive hepatocellular carcinoma in 18 dogs (2020–2025)},
journal = {American Journal of Veterinary Research},
year = {2026},
volume = {87},
number = {11},
doi = {10.2460/ajvr.26.04.0189}
}
EUVIMED